Citation Impact
Citing Papers
Oxidative Stress
2017 Standout
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis
2013
Riding the tiger – physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix
2020
Risk Associations of Glycemic Burden and Obesity With Liver Cancer—A 10‐Year Analysis of 15,280 Patients With Type 2 Diabetes
2022
Microbiota tryptophan metabolism induces aryl hydrocarbon receptor activation and improves alcohol-induced liver injury
2020
New frontiers in liver resection for hepatocellular carcinoma
2020
Ferroptosis: molecular mechanisms and health implications
2020 Standout
Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis
2013
Prospective Comparison of Spleen and Liver Stiffness by Using Shear-Wave and Transient Elastography for Detection of Portal Hypertension in Cirrhosis
2014
Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study
2011
Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells
2008
Limitations of non-invasive tests for assessment of liver fibrosis
2020
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Chemoattractant Signaling between Tumor Cells and Macrophages Regulates Cancer Cell Migration, Metastasis and Neovascularization
2009
No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm
2018
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Advances in molecular classification and precision oncology in hepatocellular carcinoma
2020
Burden of liver diseases in the world
2018 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis
2014
Crosstalk of reactive oxygen species and NF-κB signaling
2010 Standout
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
2014
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
2020
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Hepatocellular carcinoma
2012 Standout
Nonalcoholic fatty liver disease in Asia: emerging perspectives
2016
Hepatocellular carcinoma
2021 Standout
Acute-on-chronic liver failure in cirrhosis
2016
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Rational HCC screening approaches for patients with NAFLD
2021
Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
2015
Measurement of Spleen Stiffness to Evaluate Portal Hypertension and the Presence of Esophageal Varices in Patients With HCV-Related Cirrhosis
2012
Update on Biomarkers of Hepatocellular Carcinoma
2013
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Percutaneous microwave ablationvsradiofrequency ablation in the treatment of hepatocellular carcinoma
2015
Gut microbiome and health: mechanistic insights
2022 Standout
Non invasive evaluation of portal hypertension using transient elastography
2011
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The role of iron and reactive oxygen species in cell death
2013 Standout
Hepatocellular carcinoma in nonalcoholic fatty liver: Role of environmental and genetic factors
2014
Expanding the Limits of Liver Transplantation for Hepatocellular Carcinoma
2020
Oxidative stress and redox signaling mechanisms of alcoholic liver disease: Updated experimental and clinical evidence
2011
Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review
2017
Portal hypertensive bleeding in cirrhosis
2016 Standout
Non-alcoholic fatty liver disease
2021 Standout
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
2010
Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
2020
Mechanisms of Hepatic Fibrogenesis
2008 Standout
The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan®
2011
Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date
2019
Hepatitis C virus-induced hepatocarcinogenesis
2009
Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome
2015
Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial
2018
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
2016
Personalized treatment of patients with very early hepatocellular carcinoma
2016
Metabolomics: beyond biomarkers and towards mechanisms
2016 Standout
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
2014
Management of Patients With Ulcer Bleeding
2012 Standout
Accuracy of Fibroscan, Compared With Histology, in Analysis of Liver Fibrosis in Patients With Hepatitis B or C: A United States Multicenter Study
2014
Annual Incidence of Hepatocellular Carcinoma Among Patients With Alcoholic Cirrhosis and Identification of Risk Groups
2012
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
2016
Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
2018
Noninvasive assessment of liver fibrosis
2010
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
2015
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Microenvironmental regulation of metastasis
2008 Standout
Hepatic Mitochondrial DNA Depletion after an Alcohol Binge in Mice: Probable Role of Peroxynitrite and Modulation by Manganese Superoxide Dismutase
2009
Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond
2020
Noninvasive Assessment of Liver Fibrosis and Portal Hypertension With Transient Elastography
2008
Genetics and epigenetics of NAFLD and NASH: Clinical impact
2017
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
2014
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study)
2010
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients
2020
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
2014
NAFLD: A multisystem disease
2015 Standout
Surveillance for hepatocellular carcinoma
2016
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
2021
Hepatocellular carcinoma
2022 Standout
Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis
2017
Hepatocellular carcinoma: clinical frontiers and perspectives
2014
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Local and Regional Therapies for Hepatocellular Carcinoma
2020
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
2015
Hepatocellular Carcinoma
2019 Standout
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
2019
Metabolic Regulation and Function of Glutathione Peroxidase-1
2007
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
2021
Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10‐year intention‐to‐treat analysis
2017
Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology
2020
Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
2013
Insulin-Like Growth Factor (IGF) System in Liver Diseases
2018
Serum Metabolomics Analysis of Asthma in Different Inflammatory Phenotypes: A Cross-Sectional Study in Northeast China
2018
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells
2017
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
2020
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Characterization of ferroptosis in murine models of hemochromatosis
2017
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications
2015
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
2020
Radiofrequency ablation of hepatocellular carcinoma: Mono or multipolar?
2015
Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis
2012
Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
2020
Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma
2013
Transient elastography: a meta‐analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease
2012
Updates in metabolomics tools and resources: 2014–2015
2015
Nonalcoholic Fatty Liver Disease
2015 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
2021
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
2021 Standout
Works of Pierre Nahon being referenced
PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters
2014
Liver Iron, HFE Gene Mutations, and Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis
2007
A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis
2011
Liver Stiffness Measurement Versus Clinicians' Prediction or Both for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C
2006
Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment—Long-term Results
2016
Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis
2005
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis
2018
Histopathologic Comparison of Monopolar versus No-Touch Multipolar Radiofrequency Ablation to Treat Hepatocellular Carcinoma within Milan Criteria
2014
ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma
2013
Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis #
2009
PNPLA3 gene in liver diseases
2016
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
2017
The manganese superoxide dismutase Ala16Val dimorphism modulates iron accumulation in human hepatoma cells
2008
Erythromycin Infusion or Gastric Lavage for Upper Gastrointestinal Bleeding: A Multicenter Randomized Controlled Trial
2011
Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death
2005
PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis
2012
Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease
2008
Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis
2014
Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol‐related cirrhosis
2008
Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis
2011
MnSOD Overexpression Prevents Liver Mitochondrial DNA Depletion after an Alcohol Binge but Worsens This Effect after Prolonged Alcohol Consumption in Mice
2010
Epidemiology and surveillance for hepatocellular carcinoma: New trends
2020
Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis
2012
Liver insulin-like growth factor 2 methylation in hepatitis C virus cirrhosis and further occurrence of hepatocellular carcinoma
2008
Do Genetic Variations in Antioxidant Enzymes Influence the Course of Hereditary Hemochromatosis?
2010
Lipopolysaccharide-Induced Mitochondrial DNA Depletion
2011
1357 PENTOXIFYLLINE DOES NOT IMPROVE SHORT-TERM SURVIVAL IN SEVERE ALCOHOLIC HEPATITIS IN COMBINATION WITH CORTICOSTEROIDS: RESULTS OF A RANDOMIZED CONTROLLED TRIAL
2012
Eating Patterns in Patients with Compensated Cirrhosis: A Case-Control Study
2018
397 INDIVIDUAL PATIENT DATA META-ANALYSIS OF TRANSIENT ELASTOGRAPHY DIAGNOSTIC ACCURACY IN LIVER FIBROSIS ASSESSMENT OF CHRONIC HEPATITIS C PATIENTS (TE IPD STUDY)
2009
Hepatocellular Carcinoma: the Impact of NAFLD
2016
Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States
2017
Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series
2017
Caspase‐cleaved keratin‐18 fragments increase during alcohol withdrawal and predict liver‐related death in patients with alcoholic liver disease
2017
Stromal Cell–Derived Factor-1/Chemokine (C-X-C Motif) Ligand 12 Stimulates Human Hepatoma Cell Growth, Migration, and Invasion
2007
Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data
2013
Genetic Polymorphisms in Antioxidant Enzymes Modulate Hepatic Iron Accumulation and Hepatocellular Carcinoma Development in Patients with Alcohol-Induced Cirrhosis
2006
A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease
2019